Literature DB >> 21332464

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.

H H van der Zee1, L de Ruiter, D G van den Broecke, W A Dik, J D Laman, E P Prens.   

Abstract

BACKGROUND: The pathogenesis of hidradenitis suppurativa (HS) is largely unknown and the disease is difficult to treat. Patients are in high need of an effective treatment. Although it is not known whether the levels of tumour necrosis factor (TNF)-α are aberrant in HS skin, anti-TNF-α biologics are used, with variable clinical efficacy.
OBJECTIVES: To determine the cytokine profile in lesional and perilesional HS skin.
METHODS: We cultured 20 lesional and 10 normal-appearing perilesional HS skin samples, seven psoriasis and six healthy control skin samples in a transwell culture system. Two distinct cytokine bead arrays were used to measure the spectrum of inflammatory cytokines in the culture supernatant. Results from HS skin samples were compared with those of healthy and psoriasis skin.
RESULTS: The proinflammatory cytokines interleukin (IL)-1β and TNF-α as well as the anti-inflammatory cytokine IL-10 were significantly elevated in HS skin. Elevated levels of these cytokines were also found in perilesional HS skin. Fold increases relative to control skin of IL-1β, TNF-α and IL-10 in HS were 31, 5 and 34, compared with psoriasis: 4, 1 and 2, respectively. Levels of all three cytokines showed a trend towards a positive correlation with disease severity. IL-2, IL-4, IL-5 and interferon-γ were hardly detectable in HS or healthy control skin.
CONCLUSIONS: This study shows for the first time that IL-1β, TNF-α and IL-10 levels are elevated in HS skin. These data provide a rationale for therapies with biologics targeting cytokines such as TNF-α and IL-1.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332464     DOI: 10.1111/j.1365-2133.2011.10254.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  87 in total

Review 1.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

2.  Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.

Authors:  S Hessam; M Sand; M Skrygan; T Gambichler; F G Bechara
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 3.  Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.

Authors:  Massimo Cugno; Roberta Gualtierotti; Pier Luigi Meroni; Angelo Valerio Marzano
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

4.  A unique pneumopathy in a patient with skin nodules and abscesses.

Authors:  Giovanni Damiani; Nicola di Meo; Angelo Valerio Marzano
Journal:  Intern Emerg Med       Date:  2017-04-07       Impact factor: 3.397

5.  Acute fatty liver of pregnancy in a woman with ulcerative colitis and familial hidradenitis suppurativa.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2017-11-19

6.  Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa.

Authors:  Ahmed Nader; Denise Beck; Peter Noertersheuser; David Williams; Nael Mostafa
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 6.447

Review 7.  Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.

Authors:  Nicolò Scuderi; Ambra Monfrecola; Luca Andrea Dessy; Gabriella Fabbrocini; Matteo Megna; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2017-03-21

8.  Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.

Authors:  Anna Campanati; Monia Orciani; Giulia Sorgentoni; Veronica Consales; Annamaria Offidani; Roberto Di Primio
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

9.  [Acne inversa (hidradenitis suppurativa). From diagnosis to therapy].

Authors:  M Mühlstädt; F G Bechara; C Kunte
Journal:  Hautarzt       Date:  2013-01       Impact factor: 0.751

Review 10.  [Acne inversa/hidradenitis suppurativa: A challenge for the future].

Authors:  R Sabat
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.